Importance of a usual source of care in choosing low-priced generic drugs
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Son, Kyung-Bok | - |
dc.contributor.author | Lee, Eui-Kyung | - |
dc.date.accessioned | 2023-07-05T05:31:40Z | - |
dc.date.available | 2023-07-05T05:31:40Z | - |
dc.date.issued | 2022-10 | - |
dc.identifier.issn | 0263-2136 | - |
dc.identifier.issn | 1460-2229 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/112888 | - |
dc.description.abstract | Background: The potential to lower pharmaceutical spending exists if physicians prescribe low-priced generics. This study aimed to empirically investigate the determinants of choosing low-priced generic drugs in South Korea. Methods: The 2018 HIRA-NPS dataset was used for this study. Among 1.45 million individuals, we identified the patients who were prescribed atorvastatin 10 mg for more than 60 days in 2018 as the study subjects, separated the subjects into high- and low-priced groups based on their average unit price, and applied a series of logistic regression models to elucidate the factors affecting low-priced drug choice. Results: Out of 60,984 subjects, only 10,228 (17%) were categorized into the low-priced group. The majority of the subjects (31%) were prescribed drugs at the maximum reimbursement price. Age of the subject, the frequency of visits to the institution, the existence of a usual source of care, and the institution type that a subject mainly visited for prescriptions were associated with being prescribed low-priced generics. Conclusion: The association of being prescribed low-priced generics with the primary care institution and the usual source of care could be interpreted as evidence for the role of primary care in the continuity of patient-centred care. Creating health systems under which professionals act as perfect agents of a patient and/or an insurer is required. © 2022 The Author(s). Published by Oxford University Press. All rights reserved. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Oxford University Press | - |
dc.title | Importance of a usual source of care in choosing low-priced generic drugs | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1093/fampra/cmab172 | - |
dc.identifier.scopusid | 2-s2.0-85138283038 | - |
dc.identifier.wosid | 000857564000001 | - |
dc.identifier.bibliographicCitation | Family Practice, v.39, no.5, pp 791 - 798 | - |
dc.citation.title | Family Practice | - |
dc.citation.volume | 39 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 791 | - |
dc.citation.endPage | 798 | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Primary Health Care | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | BRAND-NAME | - |
dc.subject.keywordPlus | SUBSTITUTION | - |
dc.subject.keywordPlus | EXPENDITURE | - |
dc.subject.keywordPlus | PHYSICIAN | - |
dc.subject.keywordPlus | LOYALTY | - |
dc.subject.keywordPlus | DEMAND | - |
dc.subject.keywordPlus | IMPACT | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordAuthor | a usual source of care | - |
dc.subject.keywordAuthor | drug choice | - |
dc.subject.keywordAuthor | generic drugs | - |
dc.subject.keywordAuthor | low-priced generics | - |
dc.subject.keywordAuthor | South Korea | - |
dc.identifier.url | https://academic.oup.com/fampra/article/39/5/791/6505220?login=true | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.